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Abstract
Background: Multi-slice computed tomography (MSCT) can be useful before percutaneous
mitral annuloplasty (PMA) procedures to visualize the relations between the mitral valve
(MV), left circumflex artery (LCx) and coronary sinus (CS).
Methods and results: We performed a 64-slice MSCT in 196 patients (109 male; age 56.6 ±
± 11.4) with suspected coronary artery disease. A retrospective scan with ECG-gating was
performed in each. In each case 3D VR and 2D MPR reconstructions were created. We used
a subjective assessment of the quality of visualization to find the optimal phases of visualization
for LCx, CS and both vessels together (relations). The quality of visualization were graded by
2 experts on 6-points scale. LCx was usually optimally visualized in the diastolic phases (70–
–80–90%) — 126/196 (64.3%). CS was usually optimally visualized in the systolic phases
(30–40–50%) — 177/196 (90.3%). The optimal phase for parallel visualization of LCx/CS
(to observe anatomical relations) was 70–80% — 140/196 (71.4%). Good quality visualization
was obtained for both vessels: LCx: 3.6 ± 1.4/CS: 4.1 ± 1.1.
Conclusions: Reconstructions of parallel visualization of LCx/CS for PMA procedures to
observe the relations between those vessels should be considered during diastole. In addition,
independent reconstructions should also be performed optimized for the LCx and the CS.
(Cardiol J 2012; 19, 5: 459–465)
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Introduction
Mitral regurgitation is a disorder of the heart
in which the mitral valve does not close properly.
It can be caused by various mechanisms related to
structural or functional abnormalities of the mitral
valve or adjacent myocardium [1, 2]. It is the sec-
ond most common form of valvular heart disease
after aortic stenosis with a prevalence of approxi-
mately 2% of the population, affecting men and
women equally. Echocardiography is the most fre-
quent method used to confirm the diagnosis of mi-
tral regurgitation. Color Doppler flow on the tran-
sthoracic echocardiogram will reveal a jet of blood
flowing from the left ventricle into the left atrium
during ventricular systole [3, 4]. In some cases,
a transesophageal echocardiography may be needed
to determine the severity of the regurgitation [5, 6].
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Treatment of mitral regurgitation depends on the
severity of symptoms and whether there are asso-
ciated signs of hemodynamic compromise.
Percutaneous mitral annuloplasty (PMA) is an
alternative for patients with ischemic mitral regur-
gitation [7–9]. In this method the circumference of
the mitral annulus is reduced in a antero-posterior
diameter by using dedicated devices. Examples of
such devices are: MONARC (Edwards Lifesinces,
USA), CARILLON (Cardiac Dimensions, USA) and
VIACOR PTMA (Viacvor, USA) [10, 11]. Scheme
of MONARC is presented on the Figure 1. Devices
are implanted percutaneously via the coronary si-
nus ostium from the right atrium and finally to the
coronary sinus and great cardiac vein. It usually
consist of two parts — the proximal part in the co-
ronary sinus (CS) ostium and the distal part in the
distal great cardiac vein. The two parts are connect-
ed by a “bridge” that reduces circumference of the
mitral annulus.
In some anatomical variants, a close relation-
ship between the left circumflex artery (LCx) and
the CS can cause the LCx to be accidently occlud-
ed during placement of the device. This is main
reason why multi slice computed tomography
(MSCT) should be a standard procedure before
PMA. This is to allow visualization of the relation-
ships between the mitral valve (MV), the LCx and
CS so that the risk of occluding the LCx can be
minimized [9, 12]. There are no recommendations
how to visualize those structures during MSCT,
despite the knowledge that the coronary arteries
and coronary veins can be seen optimal in different
phases of the cardiac cycle [13].
The purpose of this study was therefore to
determine how optimally to visualize (and in which
part of the cardiac cycle) the LCx, the CS and their
mutual relations during MSCT.
Methods
We performed a 64-slice computed tomography
(CT) in 196 patients (109 male, age 56.6 ± 11.4
years), for suspected coronary artery disease
(CAD). We divided the patients into two groups:
Group A — those without CAD and structural heart
disease and Group B — those with CAD but with-
out structural heart disease. Patients were exclud-
ed if they had atrial fibrillation, frequent premature
heartbeats, renal insufficiency (serum creatinine
> 1.2 mg/dL), hyperthyreosis, known allergy to
nonionic contrast agents and a previously implant-
ed pacemaker with unipolar leads.
CT was performed using an Aquilion 64 scan-
ner (Toshiba Medical Systems, Japan). Scanning
with retrospective ECG-gating was performed dur-
ing a breath-hold using 64 slices with a collimated
slice thickness of 0.5 mm. A breath-hold examina-
tion was performed to adjust the scanner settings.
The helical pitch was 12.8 (best mode) and the ro-
tation time was 0.4 s. The tube voltage was strictly
dependent on the patient’s body mass index (BMI):
for BMI < 23.9 it was 120 kV at 330 mA, for
BMI = 24.0 ~ 29.9 it was 135 kV at 380 mA and for
BMI > 30.0 it was 135 kV at 430 mA. We used
a pre-selected region of interest (ROI) in the de-
scending aorta. Triggering started at 180 Hounsfield
units. On average, 100 mL of non-ionic contrast
agent (Ioperamid, Ultravist 370, Schering, Germany)
was given to each patient during the examination at
an average rate of 4.5 mL/s. The contrast agent was
given in three phases: 90 mL of contrast agent (aver-
age), then 24 mL of contrast agent followed by 16 mL
of saline flush (60%/40%) and finally 30 mL of saline.
The cut-off for heart rate (HR) was set at 65 bpm.
If the HR was higher, metoprolol succinate (Beta-
loc, Astra Zeneca, Sweden) at a dosage of 5–10 mg
was given intravenously, unless contraindicated. If
the expected HR slowing did not occurred, the pa-
tient was excluded from the study. Sublingual ni-
troglycerin was not given before image acquisition.
Reconstructions of data were performed on
Vitrea 2 workstations (Vital Images, USA; software
version 3.9.0.0 and 5.1). In each case, we created
ten (10) axial image series, as well as 3D volume
rendering (VR) reconstructions, from 0% to 90%
R-R intervals (step 10%) using a 2.0 mm slice thick-
ness to reduce the large amount of data.
The optimal phases for visualization of the LCx,






Figure 1. Scheme of the percutaneous mitral annulo-
plasty device based on MONARC device (Edwards Life-
sinces, USA).
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ship to one another) were judged on the quality of
visualization. This graded by 2 experts trained in
MSCT using a previously published 6-point scale
(Table 1) [13, 14].
The local Ethics Committee approved the
study protocol and all participants gave their writ-
ten informed consent. The study protocol con-
formed to the version of the Helsinki Convention
that was current at the time the study was designed.
Results
Hemodynamic characteristic of the patients is
presented in the Table 2. Figure 2 shows examples
of 3D visualizations of the LCx, CS and their rela-
tionship during ten (10) phases of the cardiac cy-
cle. Both vessels could usually be optimally visual-
ized — for LCx the quality of visualization was
3.6 ± 1.4 and for the CS it was 4.1 ± 1.1 (p =
= 0.0009). The quality of visualization for the LCx
during diastole and for the CS during systole are
presented in Table 3. We were not able to visualize
the LCx in only 9 (4.6%) patients. The influence of
the R-R interval on the quality of reconstructions
is given in Table 4 and Figure 3.
Visualizing the LCx
In 126 patients of 196 (64.3%) the LCx was
optimally visualized during the diastolic phases
(70–80–90%). In 69 (36.9%) patients optimal image
quality was obtained during the 80% phase, in
46 (24.6%) patients during the 70% phase, and in
11 (5.9%) patients during the 90% phase.
Visualizing the CS
In 177 patients of 196 (90.3%) the optimal im-
age quality for the CS was obtained during systole
(30–40–50%). In 118 (60.2%) patients optimal im-
age quality was obtained during the 40% phase, in
36 (18.4%) patients during the 30% phase, and in
23 patients (11.7%) during the 50% phase.
Visualizing the LCx and CS in parallel
The optimal phase for visualization both the
LCx and the CS in parallel (to observe the ana-
tomical relationship between the two vessels)
was at 70–80%. This was the case in 140 patients
of 196 (71.4%). In 76 (40.6%) patients the opti-
mal image quality was obtained during the 70%
phase and in 64 (34.2%) patients it was during the
80% phase.
Table 1. Scale of visualization used to the evaluation of left circumflex artery and coronary sinus.
Score Description
0 No vessel(s) present*
1 Vessel, length less than 5 mm, weakly contrasted and/or with a number of artifacts.
Grade 1 means that a vessel is present but very poorly visualized
2 Between score 1 and score 3
3 Vessel longer than 1 cm, better contrasted. Sometimes areas not visible or artifacts occurred
4 Between score 3 and score 5
5 Vessel well contrasted, visible clearly on all the entire length of the vessel
*When the vein is not visualized in any of the phases it has grade 0. However, this does not necessarily mean that the vein is absent — it could be
e.g. very small and therefore lower than the resolution of computed tomography scanner.
Table 2. Average values (min, max, SD) of the main cardiac function parameters for the patients included.
Average value Min. value Max. value SD
Ejection fraction [%] 62.75 8 86 9.29
End-diastolic volume [mL] 142.67 69 464 45.07
End-systolic volume [mL] 55.11 11 425 35.56
Stroke volume [mL] 86.92 39 151 20.28
Cardiac output [L/min] 5.38 1.8 13.9 1.63
Myocardial mass [g] 136.59 60 371 47.00
Myocardial volume [mL] 128.79 13 352 44.57
Heart rate [bpm] 61.16 20 83 8.39
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The optimal phase for visualizing the analyzed ves-
sels was highly reproducible (mean difference –0.4%;
95% CI –4.2–3.5%, inter-rater agreement kappa =
= 0.95). Intra-observer agreement was also excellent
(mean difference 0, inter-rater agreement kappa = 1.0).
Similarly, there was a good agreement between
observers in the evaluation of the quality of the
reconstructions. The mean values of the quality
score (LCx) were 3.10 ± 1.59 and 3.07 ± 1.56 and
the mean difference –0.04 (95% CI –1.07–1.00, in-
ter-rater agreement kappa = 0.61). There were
similar results in the repeated evaluation of the
score by the same observer (mean difference 0.0;
95% CI –1.4–1.4 and kappa = 0.66).
Figure 2. Influence of the phase of reconstruction on visualization of left circumflex artery and coronary sinus. Lateral
view of the heart in 3D volume rendering reconstructions (MSCT).
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Discussion
Percutaneous mitral annuloplasty devices was
developed to treat patient with mitral ischemic re-
gurgitation. Safety and usefulness were suggested
in human studies like AMADEUS trial [15]. Poten-
tial benefits from using of PMA procedures are: to
reshape the valvular dimensions, tighten the valve
leaflets and what is more important to reduce mi-
tral regurgitation. In the era of cardiac resynchro-
nization, cannulation of coronary sinus usually is not
a problem, but sometimes anatomy of heart vessels
can be real challenge [16].
The anatomical relationship between the LCx
and the CS is crucial for PMA. During animal studies
early in the development this technique, LCx com-
pression was reported as a serious complications.
This emphasized the importance of being able to
clearly see the anatomical relationship between the
LCx, the CS and the MV.
Several studies have confirmed the consider-
able anatomical variability in the relative positions
of the LCx, the CS and the MV. For example Ma-
selli et al. [17], examined the hearts of 61 patients
who had died of non-cardiological causes.
In the era of non-invasive visualization MSCT
can play a vital role. One of the earliest studies was
that of Tops et al. in 2007 [12]. The authors ana-
lyzed 105 consecutive patients referred for MSCT
coronary angiography. Patients were divided into
3 groups according to the presence of CAD and
heart failure. They concluded that the LCx, CS and
mitral valve can be analyzed. This paper is relevant
to our study as they used the same MSCT scanner
with retrospective gating. The authors did not ana-
lyze the influence of the phase of the RR interval
Table 3. Quality of the visualization of the left circumflex artery (LCx) and coronary sinus (CS) system
in score points for the three best visualized phases.
Score 5 Score 4 Score 3 Score 2 Score 1
Quality of visualization LCx
Phase 70% 17 9.66% 12 6.8% 10 5.68% 1 0.57% 0 0%
Phase 80% 25 14.20% 23 13.1% 7 3.79% 7 3.79% 1 0.57%
Phase 90% 5 2.84% 3 1.71% 2 1.14% 0 0% 1 0.57%
Quality of visualization CS
Phase 30% 19 10.79% 9 5.11% 2 1.14% 3 1.71% 3 1.71%
Phase 40% 61 34.66% 31 17.61% 18 10.23% 6 3.41% 2 1.14%
Phase 50% 8 4.45% 5 2.84% 9 5.11% 1 1.71% 0 0%
*Optimal phase to observe relations between LCx/CS
Figure 3. The distribution of the optimal phase of re-
construction of the left circumflex artery (LCx), corona-
ry sinus (CS) and LCx/CS. Phases 70–80–90% represen-























Table 4. Number of patients for whom optimal image quality in selected phases were achieved.
Phase Phase Phase Phase Phase Phase Phase Phase Phase Phase Impossible
0% 10% 20% 30% 40% 50% 60% 70% 80%  90% to evaluate
LCx 1 0 1 8 26 13 12 46 69 11 9
CS 1 1 1 36 118 23 4 6 6 0 0
Optimal LCx/CS* 2 0 1 2 24 7 10 76 64 1 9
*Optimal phase to observe relations between LCx/CS; LCx — left circumflex artery; CS — and coronary sinus
464
Cardiology Journal 2012, Vol. 19, No. 5
www.cardiologyjournal.org
on their ability to visualize or the quality of visua-
lization — their data sets were always reconstruct-
ed during 75% of the RR interval. The main pur-
pose of our study was to analyzed the influence of
the phase of the RR interval on the possibility of
visualizing these key vessels and the quality of vi-
sualization. We found that the best visualization of
the anatomical relations between those these ves-
sels was at 70–80% of the RR. This is comparable
with phase used by Tops et al. [12]. Nevertheless
in almost 30% of patients better visualization was
obtained in different phases.
Plass et al. [18] carried out a retrospective ana-
lysis of 50 patients who had MSCT before minimally
invasive valve surgery. They performed 64 slice CT
(GE Healthcare) in all the patients. Like Tops et
al. [12] they reconstructed their data at the 75%
phase. Their results confirmed that MSCT allows
the exact depiction and measurement of the CS,
coronary arteries and the MV with the surround-
ing tissue.
Choure et al. [19] used MSCT to examine the
hearts of 25 patients with normal mitral function and
14 with severe mitral regurgitation using a 16 slice
scanner (Philips Medical Systems) with retrospec-
tive gating. They did not give exact information about
the phase of the RR interval they used. Instead, they
reported that reconstructions were created at the
desired phases during the cardiac cycle. Exact infor-
mation about RR interval is not available in this pub-
lication — the only information is that reconstruc-
tions were created at desired phases during the car-
diac cycle. Nevertheless they confirmed that there
is significant variability in the relative anatomical
positions of the LCx, CS, and MV annulus.
Despite the differences between these pub-
lished studies, there is agreement about the use-
fulness of MSCT especially in identifying patients
in whom this method could lead to serious compli-
cations, thus helping in the precise pre-selection of
patients and planning the procedure individually for
qualified patients.
Earlier publications including studies from our
unit have shown that the phase of the RR interval
at which reconstructions are performed is an im-
portant factor affecting the quality of visualization
[13, 14, 20]. This is especially important when ves-
sels other then coronary arteries need to be ana-
lyzed. Arteries are optimally visualized during di-
astole (70–80–90% of the RR interval). This is the
basis for MSCT with prospective gating where the
best quality is only during diastolic phases. In con-
trast, in retrospective scanners all phases are
scanned and any phase can be reconstructed with
full quality. However the major disadvantage of ret-
rospective reconstruction is that the patient is ex-
posed to high doses of radiation.
It has been reported that coronary veins are
seen optimally during systole (30–40–50% of the
RR interval). However there is still some uncertain-
ty about how best to visualize both coronary arter-
ies and coronary veins. The same problem is met
during pre-visualization of the coronary venous sys-
tem before cardiac resynchronization therapy
(CRT). During these procedures the coronary ar-
teries are visualized as a basic procedure, and the
coronary veins are analyzed as a secondary proce-
dure to evaluate their anatomy, in particular the
coronary sinus ostium and target veins for CRT.
This poses much the same challenges as percuta-
neus mitral annuloplasty procedures. The next step
in the development of PMA connection with CRT.
The basis is that in patients with heart failure (po-
tential candidates for CRT) mitral regurgitation of-
ten coexists with heart failure. In such cases addi-
tional visualization of coronary venous system
should be added [13].
There are some reports existing, where CRT
devices were implanted in the group of patients af-
ter PMA procedures. Hoppe et al. [21] reported
group of three patients from AMADEUS trial un-
derwent CRT after 6 months of follow up. This small
study proofed the feasibility of positioning a left ven-
tricle lead after permanent implantation of PMA de-
vice (CARILLON).
Pre-visualization of the vessels in diastole (co-
ronary arteries) and in systole (coronary veins) can
be used in the future to evaluate target veins be-
fore cardiac resynchronization.
Limitations of the study
Most of the limitations are related to the MSCT
as a method. The dose of radiation is substantial,
as well as amount of contrast agent. However the
risk of iatrogenic myocardial infarction due to in
accidental occlusion of the LCx during PMA is prob-
ably higher than the limitation inherent in MSCT.
Our study is about methodology, our aim be-
ing only to evaluate how to optimally visualize the
coronary vessels and their mutual relations on
MSCT. The results have only practical implications
for performing MSCT, and not for practical perform-
ing of PMA procedures.
Conclusions
It is possible to visualize the CS and LCx in
relation to the mitral valve during MSCT. Recon-
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structions of parallel visualization of both the LCx
and the CS to determine the relations between
these vessels before PMA procedures should be
considered during diastolic phase. Additional inde-
pendent reconstruction optimal for LCx (mostly
diastolic) as well as CS (mostly systolic) should also
be performed.
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